Delivery Order SPE2DB22D9311-SPE2DB25FP7AT
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order, which has an ultimate completion date of September 22, 2025, is for XOLAIR 150 mg/ml syringes. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, valued at $1,547.40, operates under a firm fixed-price structure with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,325.76 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes and is expected to be completed by September 15, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,284.40 on July 21, 2025, for Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and carries no set-aside designation. The product will be delivered to Park Ridge, Illinois, and is funded through the Medical Supply Chain division of the Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xolair 75 mg/0.5 ml syringes. The contract, valued at $2,321.10 with a firm fixed-price structure, is set to be completed by September 30, 2025. This delivery order represents a standard procurement action within DMS Pharmaceutical Group's broader relationship with the DLA,...
- The Defense Logistics Agency awarded a delivery order valued at $12,379.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group is registered in the System for Award Management and has maintained...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for Xolair 300 mg/2 ml auto-injector pharmaceutical products, with a ceiling value of $1,712.23. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency for Xolair 150 mg/mL syringes. The contract, which carries a firm fixed-price structure with an ultimate completion date of September 26, 2025, was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- SPE2DB22D9311Indefinite Delivery Contract
- SPE2DB22D9311-SPE2DB25FP7ATDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,162.88 by the Defense Logistics Agency on September 23, 2025, for the supply of Xolair 300 mg/2 ml syringes. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for ultimate completion by October 15, 2025, and will be performed at the company's Park Ridge facility. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role as a critical supplier within the federal pharmaceutical supply chain. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. This overarching contract, awarded under the SPE2DB program, enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The IDC encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories, establishing DMS Pharmaceutical Group as a foundational supplier for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/23/25 |